1例螺内酯致男性肝硬化患者乳房发育的不良反应分析 |
投稿时间:2016-09-06 修订日期:2017-01-05 点此下载全文 |
引用本文:孙钟慧,王铀,段海洁,谭月桂,梁乐,姚鸿萍.1例螺内酯致男性肝硬化患者乳房发育的不良反应分析[J].药学实践杂志,2017,35(2):165~166,170 |
摘要点击次数: 1683 |
全文下载次数: 1013 |
|
|
中文摘要:目的 分析1例男性肝硬化患者服用螺内酯后出现乳房发育的不良反应,探索可能原因,提高药学服务水平。方法 临床药师结合患者的基础疾病、用药史等诊疗经过,查找国内外相关文献,对不良反应产生原因进行分析。结果 患者停用螺内酯后,乳房疼痛减轻至消失,推测螺内酯是导致患者乳房发育的可疑药物。结论 临床药师通过关注药品不良反应,可以为临床提供药物信息和更好的药学服务。 |
中文关键词:螺内酯 肝硬化 乳房发育 药品不良反应 |
|
A case study of spironolactone induced gynecomastia in one male patient with cirrhosis |
|
|
Abstract:Objective To study one male patient with cirrhosis for spironolactone induced gynecomastia and promote clinical pharmacists providing better pharmaceutical cares.Methods Based on the patient's diseases and medication history, clinical pharmacists searched related literature and analyzed the cause of gynecomastia for the patient.Results The patient's breast pain was relieved and finally disappeared after termination of spironolactone. Therefore, spironolactone was suspected to be the drug to cause gynecomastia.Conclusion Clinical pharmacists can improve pharmaceutical cares by carefully monitoring the adverse reactions and selecting appropriate medications. |
keywords:spironolactone cirrhosis gynecomastia adverse drug reactions |
查看全文 查看/发表评论 下载PDF阅读器 |
|
关闭 |
|
|
|